Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial and Will Soon Begin Phase 2a Kidney Dialysis and Phase 1 Fabry Disease Trials**

Message: 3rd Quarter Financial Statements

BDAZ - Like you I found the wording of the 23 Feb release challenging to interpret. I have chosen, rightly or wrongly to interpret as the IND was filed on 23 Feb and am now waiting (impatiently) for the 30 day waiting period to pass. If I am correct in this interpretation this could literally be the beginning of the launch into the stratosphere for our share price.IMO

We will find out in a few short days now.


New Message
Please login to post a reply